Patents by Inventor Chris Hollowood

Chris Hollowood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENE THERAPY
    Publication number: 20230277689
    Abstract: An AAV vector comprising a nucleotide sequence encoding Factor I or Factor H or a fragment or derivative thereof. The vector is useful for treating or preventing a complement-mediated disorder of the eye.
    Type: Application
    Filed: December 16, 2022
    Publication date: September 7, 2023
    Inventors: Christian Groendahl, Tim Funnell, Chris Hollowood
  • VECTOR
    Publication number: 20230175016
    Abstract: The present invention provides a viral vector comprising a nucleotide sequence encoding a complement protein, wherein the nucleotide sequence is operably linked to a podocyte-specific promoter and/or the viral vector is capable of specifically transducing podocytes.
    Type: Application
    Filed: June 30, 2021
    Publication date: June 8, 2023
    Inventors: Alan William Griffith, Lukas Stanczuk, Valeryia Kuzmuk, Chris Hollowood, Dominic Schmidt, Moin Ahson Saleem-Uddin, Gavin Iain Welsh
  • Gene Therapy
    Publication number: 20190255193
    Abstract: An AAV vector comprising a nucleotide sequence encoding Factor I or a fragment or derivative thereof.
    Type: Application
    Filed: October 27, 2016
    Publication date: August 22, 2019
    Inventors: Christian Groendahl, Tim Funnell, Chris Hollowood